Biohaven Pharmaceutical Holding Co. Ltd. said Albert Cha notified the company of his intent to step down as the company's director, effective Sept. 7.
The company said Cha's resignation was not a result of any disagreement with the company or the board.
New Haven, Conn.-based Biohaven Pharmaceutical is a clinical-stage biopharmaceutical company that develops product candidates to treat neurological diseases, including rare disorders.